BiotechTube
Home/Maravai LifeSciences/Carl W. Hull
CW

Carl W. Hull

Chairman and Chief Executive Officer

Maravai LifeSciences

Therapeutic Areas

Genetic MedicineInfectious DiseaseOncologyRare Diseases

Maravai LifeSciences Pipeline

DrugIndicationPhase
CleanCap® Technology PlatformmRNA Therapeutics & VaccinesCommercial
TriLink Custom mRNA ManufacturingVarious genetic medicinesCommercial
Cygnus HCP Assay PlatformBiologics Safety TestingCommercial
Modified Nucleotide PortfolioEnhanced mRNA therapeuticsResearch/Commercial
NTP ManufacturingNucleic acid synthesisCommercial

Leadership Team at Maravai LifeSciences

KM
Kevin M. Herde
Chief Financial Officer
MJ
Michael J. Bannon
Chief Legal Officer and Corporate Secretary
TM
Trey Martin
President, Nucleic Acid Production
TD
Toby D. Wilson
President, Biologics Safety Testing
TJ
Tracy J. Krumme
Senior Vice President, Global Human Resources
MJ
Martin J. D. Allis
Director
JA
John A. Deford
Director
KO
Kurt O. Wood
Director
DB
David B. Singer
Director
JR
James R. Sulat
Director
View full Maravai LifeSciences profile